REAL-WORLD 30-DAY READMISSION PATTERNS AMONG COMMERCIALLY INSURED PATIENTS WITH METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)

Kim, GP; Surinach, A; Cockrum, P

VALUE IN HEALTH, 2022; 25 (7): S310